FindTrial
Sign In

Expression of PD-1/PD-LS and CTLA-4 in immonoglobulin G4-related ophthalmic disease and ocular adnexal MALT lymphoma and related immune mechanism

Expression of PD-1/PD-LS and CTLA-4 in IgG4-ROD and ocular adnexal MALT lymphoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039323
Enrollment
Unknown
Registered
2020-10-23
Start date
2020-12-01
Completion date
Unknown
Last updated
2021-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ocular adnexal disease

Interventions

MALT lymphoma group:Nil
healthy control group:Nil

Sponsors

Sichuan University West China Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: IgG4-ROD group and MALT lymphoma group meet the diagnostic criteria for IgG4-rod and MALT lymphoma respectively. Healthy controls are healthy subjects matched in gender, age and BMI.

Exclusion criteria

Exclusion criteria: Patients with incomplete data records. Under the age of 18 years.

Design outcomes

Primary

MeasureTime frame
PD-1;PD-Ls;CTLA-4;IgG4;—

Countries

China

Contacts

Public ContactWeimin He

Sichuan University West China Hospital

hewm888@hotmail.com+86 18980601753

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026